Whitepaper
10 Oct 2023
Achieving faster formulation of solid oral dosage forms for First-In-Human supplies using drug-in-capsule approach
PDF 503 kB
Content provided by our supplier
Almac Group Ltd
-
GB
-
2015On CPHI since
-
4Certificates
-
5000+Employees
Company types
Primary activities
Other Content from Almac Group Ltd (16)
-
News Almac Group Expands Commercial Manufacturing and Packaging as well as Peptide Production Capacity at Headquarters with Two New Purpose-Built Facilities
The Almac Group has today announced the completion of two new purpose-built facilities at its headquarters in Craigavon, Northern Ireland meeting client demand in commercial manufacturing and packaging as well as peptide production.
-
Brochure Think Almac Sciences
Your integrated API and analytical services provider -
News Almac Group opens a new custom-built GMP warehouse at its Global Headquarters
The new custom-built facility will consolidate the existing warehouses to support all manufacturing and laboratory activities. -
Brochure Almac Pharma Services
Tailor-made Pharmaceutical Development & Commercial Solutions -
News Almac Group Wins Life Sciences Team of the Year
Almac Sciences’ Technology Group was selected as the winner of the “Life Sciences Team of the Year” category during this year’s Irish Life Sciences Awards ceremony, held on 6 July 2023 at Crowne Plaza Hotel, Dublin.. -
News Almac Sciences and University College Dublin BROADEN Continuous Flow Chemistry Collaboration
Strengthened collaboration with University College Dublin (UCD) that will focus on the development of novel continuous flow protocols for accessing new industrially relevant drug targets. -
Brochure Ultra-Low Temperature Packaging & Distribution Solutions
With more than 50 years’ experience, we offer a wide range of specialised packaging solutions to meet, and deliver your product launch and ongoing commercial needs. -
News Almac Group Awarded with Six CDMO Leadership Awards Across all Core Categories
Overall recognition received for compatibility, expertise, quality and reliability. -
Brochure Tailor-made Product Launch Solutions
Balancing speed with precision, our flexible suite of offerings provides you with a reliable, effective, and expert approach to support the successful and timely introduction and launch of your new product and market penetration into new territories. -
News Almac Group secures HPRA certification for biologics testing
Health Products Regulatory Authority (HPRA) has certified Almac Sciences Ireland (ASI) facility for testing of biologics after a successful audit -
Brochure Almac Pharmaceutical Development
Our product development service spans early to late phase clinical programs, offering technical experience and dedicated project management, and a track record of on-time delivery from state-of-the-art facilities. -
News Almac Group Completes First Stage of GMP API Facility Expansion
Expanded GMP manufacturing facility now operational for use in clinical and / or commercial manufacturing -
Brochure Biocatalytic Oligonucleotide Synthesis Technology
Let Almac BOOST your oligo synthesis -
Brochure Think Almac...Radiolabelling
Non-GMP & GMP stable & radiolabelling expertise14C labelling of drug substance for human AME studies
Stable & radiolabelled metabolite synthesis
Specialist expertise in peptide & bioconjugate 14C labelling
QC, Analytical & QA integration
MHRA regulatory approved for 14C GMP manufactureof drug substance -
Brochure Think Almac...Superior peptide solutions
Over 30 years’ experience in peptide manufactureRapid throughput, high quality manufacture
Customised supply plan for your project needs
Free consultation on peptide design & manufacturability
Smooth transition to scale-up & cGMP manufacture
Strong emphasis on project management & customercare throughout project lifetime -
Brochure Think Almac...Preformulation development
As a world leader in pharmaceutical services, Almac delivers early formulation development workprograms for DRF/PK/tox studies. Designed to maximise solubility and bioavailability withoutcompromising on chemical stability, the studies accelerate drug development to the clinic and minimizerisk in any downstream activities. Almac offer bespoke work packages specifically tailored to thephysiochemical properties of the API (BCS class II, III, or IV) for solubility or permeability enhancement.
Position your company at the heart of the global Pharma industry with a CPHI Online membership
-
Your products and solutions visible to thousands of visitors within the largest Pharma marketplace
-
Generate high-quality, engaged leads for your business, all year round
-
Promote your business as the industry’s thought-leader by hosting your reports, brochures and videos within your profile
-
Your company’s profile boosted at all participating CPHI events
-
An easy-to-use platform with a detailed dashboard showing your leads and performance